Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer
โ Scribed by Merrill S. Kies; Steven T. Rosen; Tat-Kin Tsang; Ramananda Shetty; Philip A. Schneider; Carl B. Wallemark; Thomas W. Shields
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 511 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The combination of Cis-dichlorodiammineplatinum (II) (CisDDPt) + 5-Fluorouracil (5-FU) was compared with two CisDDPt analogues + 5-FU [Iproplatin (CHIP) + 5-FU and Carboplatin (CBDCA) + 5-FU] for relative efficacy against advanced stage squamous cell lung tumors (LC-12) in Balb/c mice. At equitoxic
Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt